HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haemophilus Vaccines (Vaccine, Haemophilus)

Vaccines or candidate vaccines containing antigenic polysaccharides from Haemophilus influenzae and designed to prevent infection. The vaccine can contain the polysaccharides alone or more frequently polysaccharides conjugated to carrier molecules. It is also seen as a combined vaccine with diphtheria-tetanus-pertussis vaccine.
Also Known As:
Vaccine, Haemophilus; Haemophilus Vaccine; Hemophilus Vaccines; Vaccines, Haemophilus; Vaccines, Haemophilus influenzae; Vaccines, Hemophilus; Haemophilus influenzae Vaccines
Networked: 37 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Barrett, Lisa L: 2 articles (08/2021 - 01/2021)
2. Benchimol, Eric I: 2 articles (08/2021 - 01/2021)
3. Bessissow, Talat: 2 articles (08/2021 - 01/2021)
4. Carman, Nicholas: 2 articles (08/2021 - 01/2021)
5. Carroll, Matthew W: 2 articles (08/2021 - 01/2021)
6. Jones, Jennifer L: 2 articles (08/2021 - 01/2021)
7. Marshall, John K: 2 articles (08/2021 - 01/2021)
8. McNeil, Shelly A: 2 articles (08/2021 - 01/2021)
9. Melmed, Gil Y: 2 articles (08/2021 - 01/2021)
10. Pham-Huy, Anne: 2 articles (08/2021 - 01/2021)

Related Diseases

1. Infections
2. Tetanus
3. Whooping Cough (Pertussis)
4. Poliomyelitis (Polio)
01/01/2021 - "We assessed whether delayed vaccination against diphtheria, tetanus, acellular pertussis, polio, and Haemophilus influenzae type b (Diphtheria, Tetanus, acellular Pertussis - Inactivated Polio vaccine - Haemophilus influenzae type b [DTaP]) was associated with a reduced risk of new cases of AD before age 1 year in Denmark. "
11/01/1998 - "Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age."
12/15/2003 - "In this study, autoimmune diabetes-prone non-obese diabetic (NOD) mice were treated with two multivalent diphtheria, tetanus, pertussis, poliomyelitis and haemophilus vaccines (diphtheria, tetanus, acellular pertussis, inactivated polio (DTaP-IVP) or DTaP-IVP/Haemophilus influenza type b (Hib)) intraperitoneally at each of 10, 12 and 14 weeks of age. "
03/22/2007 - "Furthermore, co-administration of the combination vaccine with a combined diphtheria/tetanus/acellular pertussis/inactivated poliomyelitis vaccine/Haemophilus influenzae type b-TT conjugate (DTaP/IPV-Hib) vaccine to New Zealand white rabbits at a different injection site did not affect the anti-pneumococcal polysaccharide and anti-PorA antibody titres. "
09/03/2013 - "In this pilot case-control study, we assessed immunocompetence in 24 patients after alemtuzumab treatment by measuring antibody responses to 3 vaccines (diphtheria, tetanus, and poliomyelitis vaccine, Haemophilus influenzae type b and meningococcal group C conjugate vaccine, and pneumococcal polysaccharide vaccine). "
5. Diphtheria

Related Drugs and Biologics

1. Vaccines
2. Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)
3. Polysaccharides (Glycans)
4. Subunit Vaccines
5. Inactivated Vaccines
6. Proteins (Proteins, Gene)
7. Glycoconjugates
8. Diphtheria Toxoid (Vaccine, Diphtheria)
9. Hexavac
10. Conjugate Vaccines